BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17036937)

  • 1. PBMs raise the curtain.
    Sipkoff M
    Manag Care; 2006 Sep; 15(9):38-40, 43. PubMed ID: 17036937
    [No Abstract]   [Full Text] [Related]  

  • 2. Rebates and other drug-cost issues.
    Penna P
    Manag Care Interface; 2003 May; 16(5):39-40. PubMed ID: 12789863
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost not the primary factor driving drug coverage.
    Capitation Rates Data; 2000 May; 5(5):51-3. PubMed ID: 11066970
    [No Abstract]   [Full Text] [Related]  

  • 4. The managed care prescription benefit. Challenged by shifting care and shifting costs.
    Bender J
    AAPPO J; 1991; 1(4):11-8. PubMed ID: 10149632
    [No Abstract]   [Full Text] [Related]  

  • 5. Need for integrated data in pharmacy benefits.
    Martens G; Clor GE
    J Health Care Benefits; 1993; 3(1):57-60. PubMed ID: 10130352
    [No Abstract]   [Full Text] [Related]  

  • 6. The evolving role of pharmacy benefits management firms in a managed care environment.
    O'Leary JS
    Benefits Q; 1995; 11(3):24-33. PubMed ID: 10151118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting gears.
    Tweed V
    Bus Health; 1994 May; 12(5):28-9, 32, 34 passim. PubMed ID: 10134334
    [No Abstract]   [Full Text] [Related]  

  • 8. A whole new world?: pharmaceutical responses to the managed care revolution.
    Balto DA
    Food Drug Law J; 1997; 52(1):83-98. PubMed ID: 10346712
    [No Abstract]   [Full Text] [Related]  

  • 9. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs.
    Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334
    [No Abstract]   [Full Text] [Related]  

  • 10. MCO-PBM (managed care organization-prescription benefit management) partnerships holding down drug trend.
    Alexander W
    Exec Solut Healthc Manag; 1998 Dec; 1(10):1, 4-6. PubMed ID: 10338773
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plans continue to raise copayments.
    Manag Care; 2005 Sep; 14(9):59. PubMed ID: 16238260
    [No Abstract]   [Full Text] [Related]  

  • 13. The pitfalls and potential of pharmacy risk.
    Lawrence J
    Manag Care; 1998 May; 7(5):45-6, 51-2. PubMed ID: 10180140
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of randomized controlled trials in organizational decision making: a cost-minimization approach.
    Cher DJ; Maclure M
    Am J Manag Care; 2000 Aug; 6(8):894-904. PubMed ID: 11186501
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacy benefit management: the right Rx?
    Etheredge L
    Res Agenda Brief; 1995 Apr; (1):1-11. PubMed ID: 12856664
    [No Abstract]   [Full Text] [Related]  

  • 17. The evolving pharmacy benefit market.
    Navarro RP
    Med Interface; 1994 May; 7(5):65-7, 70. PubMed ID: 10134345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When success sours: PBMs under scrutiny.
    Carroll J
    Manag Care; 2002 Sep; 11(9):20-6. PubMed ID: 12369344
    [No Abstract]   [Full Text] [Related]  

  • 19. An industry in evolution.
    Blissenbach HF
    Med Interface; 1995 Oct; 8(10):80-1, 88. PubMed ID: 10152328
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulatory and legislative challenges facing managed care.
    Giaquinta D
    Manag Care Interface; 2000 Jul; 13(7):47-9. PubMed ID: 11183928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.